期刊文献+

奥曲肽预防ERCP术后胰腺炎的疗效 被引量:6

Preventive effect of octreotide on pancreatitis after ERCP
下载PDF
导出
摘要 目的 探讨奥曲肽对内镜逆行胰胆管造影 (ERCP)术后高淀粉酶血症及急性胰腺炎的预防作用。 方法 行ERCP患者共 1 3 2例 ,随机分为两组 :预防组 67例 ,分别于术前 3 0min及术后 2 4hq8h皮下注射奥曲肽 0 .1mg;对照组 65例 ,术前、术后不用奥曲肽注射。术前、术后 3h及 2 4h检测血清淀粉酶 ,同时观察腹痛及胰腺炎的发生情况。 结果 预防组ERCP术后血淀粉酶分别是 2 96.2 4± 2 73 .71IU/L和 3 55.61± 3 1 8.66IU/L,明显低于对照组 ( 594 .96± 562 .73IU/L和 651 .1 9±53 4 .84IU/L,P <0 .0 1 )。预防组发生急性胰腺炎 1例 ( 1 .4 9% ) ,对照组发生 5例 ( 7.69% ,P <0 .0 1 )。 结论 奥曲肽能有效预防ER Objective To investigate the preventive effect of octreotide on acute pancreatitis and hyperamylasemia after ERCP. Methods 132 patients who underwent ERCP were divided randomly into 2 groups:the preventive group was received octreotide 0.1mg,30minutes before and 24 hour q8h after ERCP respectively;the control group received nothing.The mean concentration of serum amylase at 3h and 24h after ERCP was measured in all patients,and the positive rates of abdominal pain and pancreatitis after ERCP were observed. Results The mean concentration of serum amylase (IU/L)at 3h and 24h post ERCP was 296.24±273.71 and 355.61±318.66 in the preventive group ,and 594.96±562.73 and 651.19±534.84 in the control group (P<0.01).Acute pancreatitis was occurred in 5 cases (7.69%)of the control group and in 1 cases ( 1.49 %) of preventive group after ERCP(P<0.01). Conclusion Octreotide can prevent effectively hyperamylasemia and acute pancreatitis after ERCP.
出处 《现代实用医学》 2001年第1期21-22,共2页 Modern Practical Medicine
关键词 内镜逆行胰胆管造影 胰腺炎 高淀粉酶血症 奥曲肽 ERCP ERCP Pancreatitis Hyperamylasemia Octreotide
  • 相关文献

参考文献4

二级参考文献37

  • 1龚彪,周岱云.经内镜胆管引流术375例评价[J].中华消化内镜杂志,1997,14(2):77-80. 被引量:65
  • 2Sherman S, ERCP and endoscopic sphincterotomy induced pancreatitis. Am J Gastroenterol,1994,89:303-305.
  • 3Sherman S, Lehman GA. ERCP and endoscopic sphincterotomy-induced pancreatitis. Pancreas,1991,6:350-367.
  • 4Freeman ML, Nelson DB, Sherman S, et al. Complleations of endoscopic biliary sphincterotomy N Engl J Med,1996,335 : 909-918.
  • 5Laugier R, Bernard JP, Berthezene P, et al. Changes in pancreatic excrine secretin with age: pancreatic excrine secretion does decrease in the elderly. Digestion, 1901,50:202-211.
  • 6Kozarek RA. Biliary dyskinesia: are we any closer to defining the entity? Gastrointes Endosc Clin North Am,1993,3:167-178.
  • 7Mehta SN,Pavone E,Bouchard S,et al.Predictors of post-ERCP pancreatitis in patients with suspected.choledocholithiasis, A.M J Gastroenterol, 1996, 91: 1938.
  • 8Vandervoort J, Tham Tck, Wong Rck, et al. Identification of risk factors for ERCP related pancreatitis,Gastrointest Endosc,1997,34:234.
  • 9Johnson G, Cass O, Geenen J. Post ERCP pancreatitis: a comparative study of patients with and without pancreatic duct injection at the time of ERCP. Gastointest Endose,1993,39:284.
  • 10Sherman S, Hawes RH, Rathgaber SW. Post-ERCP pancreatitis: randomized, prospective study comparing a low and highosmolality contrast agent. Gastrointest Endosc,1994,40:422-427.

共引文献97

同被引文献61

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部